2022 Annual Meeting Meeting Banner

Call for Abstracts

Welcome to the ASBrS 23rd Annual Meeting Call for Abstracts! Please review the guidelines below for helpful information on preparing and submitting your abstract for the Annual Meeting. Please email any questions regarding the submission process to abstracts@breastsurgeons.org or call 877-992-5470 (M–F 8:30 am–5:00 pm et).

All abstracts must be submitted through our online submission portal no later than 3:00 pm et on November 3, 2021. Authors may submit 1 or more abstracts for consideration for presentation at the Annual Meeting. Please review our abstract guidelines for each submission type below.

 Click Here to submit your abstract.


Abstract Submission Guidelines Overview

  • All abstracts for the 2022 Annual Meeting must be submitted online through our online submission portal.
  • Abstracts may not contain data that have been previously presented or will be presented or published prior to the 2022 Annual Meeting.
  • All abstract submissions are subject to a non-refundable $60 submission fee.
  • Disclosure Declaration: The ASBrS disclosure policy promotes balance, independence, objectivity, and scientific rigor in all of its educational activities through the disclosure of financial or non-financial/strategic business relationships or partnerships (relationships) and mitigation of relevant relationships. The relationships requiring disclosure are outlined in the ASBrS CME Activity Disclosure Policy. All authors are expected to disclose all relationships with ineligible companies.
    • Ineligible Company: “A for-profit entity that develops, produces, markets, or distributes drugs, devices, services or therapies used to diagnose, treat, monitor, manage, and alleviate health conditions. This definition is not intended to include non-profit entities, entities outside of the healthcare sector, or entities through which physicians provide clinical services directly to patients.”
    • If the first presenting author is employed by an ineligible company as defined by the ACCME, an alternate presenter who does not have a relevant employment relationship must be named if the abstract is selected for presentation in an oral abstract session. Oral abstract presenters will also be subject to the same disclosure review and management strategies as faculty.
  • Identification of Clinical Trials: Indicate whether the research is a clinical trial. A clinical trial is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.
    • Though clinical trial registration is not required for abstract submission, publication, or presentation, certain clinical trials are required to be registered by law and/or prior to journal publication. If a clinical trial is already registered, the first author will be asked to provide the name of the registry and the trial registration number during the abstract submission process.

Traditional Abstracts

  • Institutional names are not to be included anywhere in the title or body of the abstract.
  • Case reports will not be accepted.
  • Word limit – 500 words or less. Abstracts that exceed the word limit will not be accepted.
  • Abstracts submitted may include 1 table OR 1 figure. Abstracts submitted with more than 1 table or 1 figure will not be accepted.

Late Breaking Abstracts

  • The ASBrS will accept late breaking abstracts specific to only prospective clinical trials for which patients signed informed consent prior to participation. Abstracts that concern other data types will not be considered.
  • To qualify as a late breaking abstract, submit a placeholder abstract by the general abstract deadline of November 3, 2021. The placeholder abstract should include background, methods and details of the clinical trial sample size, and potential implications of trial findings.
  • The final version of the abstract is due on February 4, 2022. The final version of the late breaking abstract must include the final results.
  • These abstracts will be considered by the Publications Committee for presentation, and those accepted will be notified.

Current Accruing Prospective Clinical Trial Abstracts

  • Abstracts submitted in this section should describe the primary and secondary objectives of the trials, targeted accrual, sites the trial is open at, date of activation, anticipated study length, and trial design.
  • Abstracts submitted to this category will be considered for poster presentation only.

Presentation Types

All abstracts will be reviewed by the ASBrS Publications Committee. Presentation dates are tentative and subject to change. The top abstracts will be selected for presentation in 1 of the following presentation formats:

  • Oral: Oral presentations will be given during the Scientific Session on Friday, April 8, and Saturday, April 9, 2022. Each presenter will be given 6 minutes for their presentation, followed by 2-3 minutes for questions. (In order to be eligible for acceptance, you must have an author who will be available to present during the assigned session.)
  • Quick Shot: Quick Shot presentations will be given on Saturday, April 9, 2022. Each presenter will be given 3 minutes for their presentation, which will be followed by a 2-minute discussion period. (In order to be eligible for acceptance, you must have an author who will be available to present during this session.)
  • Poster: The Scientific Poster Session and Reception will be held on Friday, April 8, 2022. Your abstract’s presenter must be available to discuss the poster with interested meeting attendees during this session. (Note: The American Society of Breast Surgeons will provide thumbtacks and an 8-foot-wide by 4-foot-high carpeted, framed board on which to mount your poster.)

Opportunities for Publication

  • Accepted abstracts will be published online in the Annals of Surgical Oncology.
  • Authors of abstracts accepted for Oral and Quick Shot presentations and selected poster presentations are invited to submit a manuscript for possible publication in the October issue of the Annals of Surgical Oncology. All manuscripts must be submitted by March 29, 2022. No extensions will be given for this deadline.
  • Fellows, residents, and medical trainees presenting an Oral or Quick Shot presentation are required to submit a manuscript for possible publication in the October issue of the Annals of Surgical Oncology in order to be considered for the George Peters Award or Scientific Presentation Award. All manuscripts must be submitted by March 29, 2022. No extensions will be given for this deadline. If a manuscript is not submitted, fellows, residents, and medical trainees will not be eligible for either of these awards.

Special Awards for Breast Fellows and Residents

Oral and Quick Shot presentations by a breast fellow will be considered for the following:

  • The George Peters Award for the best abstract presented by a breast fellow. (Fellows eligible for this award are required to submit a manuscript to Annals of Surgical Oncology by March 29, 2022.) The award was established by the Society to honor Dr. George N. Peters, who was instrumental in bringing together the Susan G. Komen Breast Cancer Foundation, The American Society of Breast Surgeons, the American Society of Breast Disease, and the Society of Surgical Oncology to develop educational objectives for breast fellowships. The educational objectives were first used to award Komen Interdisciplinary Breast Fellowships. Subsequently, the curriculum was used for the breast fellowship credentialing process that has led to the development of a nationwide matching program for breast fellowships.

Oral and Quick Shot presentations by a trainee will be considered for the following:

  • The Scientific Presentation Award for the best paper presented by a medical student, resident, or fellow. (Medical students, residents, or fellows eligible for this award are required to submit a manuscript to Annals of Surgical Oncology by March 29, 2022.)

A prize of $1,000 will be granted to the winner of the George Peters Award and $500 to the winner of the Scientific Presentation Award—both of which are supported by The American Society of Breast Surgeons Foundation.

All Oral presentations will be considered for the following:

  • The Scientific Impact Award for the best paper as voted on by the audience. The winner of the Scientific Impact Award receives a plaque.

CME Clinical Content Validation

The American Society of Breast Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Before you submit your abstract, please keep in mind ACCME’s Policy on Content Validation: All the recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. The ASBrS cannot advocate for, or promote, practices that are not, or not yet, adequately based on current science, evidence, and clinical reasoning. The ASBrS cannot advocate for unscientific approaches to diagnosis or therapy, or recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.